NLS Pharmaceutics AG NLSP
2.91 0.00 (+0.00%)
Dec 12, 2025, 9:30 AM EST
2.91 Day range 3.51
52-week range unavailable
- YTD
- -86.21%
- 1 year
- -92.46%
Latest period ending Dec 31, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| -2.05M | -2.99M | -6.55M | -11.86M | -2.30M | |
| -7.18M | -3.25M | -6.76M | -11.95M | -2.86M | |
| -1.71 | -0.78 | -1.90 | -40.00 | -16.40 |
Balance sheet
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 1.67M | 1.15M | 8.95M | 5.43M | 93.71K | |
| 2.23M | 2.31M | 9.28M | 5.76M | 1.21M | |
| 826.76K | 3.51M | 6.00M | 5.22M | 10.20M | |
| 1.41M | -1.20M | 3.28M | 542.39K | -8.98M |
Cash flow
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| -705.00K | -3.00M | -5.96M | -14.94M | -729.39K | |
| 161.00K | 91.00K | -196.00K | -39.56K | 0 | |
| 89.00K | 2.40M | 1.11M | 20.34M | 503.52K | |
| -6.00K | 103.00K | -191.00K | -39.56K | 0 | |
| -496.00K | -670.00K | -5.68M | 5.34M | -126.56K |